Synthetic Biology Industry

The global synthetic biology market was valued at USD 16.22 billion in 2024 and is projected to experience significant growth, with a compound annual growth rate (CAGR) of 17.30% from 2025 to 2030. This growth can be attributed to the emergence of various applications of synthetic biology, particularly in areas such as multiplexed diagnostics, cellular recording, and therapeutic genome editing. As these applications gain traction, they are expected to drive a substantial increase in the demand for synthetic products throughout the forecast period. Moreover, the integration of synthetic biology techniques and products into sectors such as energy and chemicals is anticipated to further enhance overall market growth. As the applications of synthetic biology continue to diversify, its utility is likely to expand, leading to broader adoption and accelerated market development.

The impact of the COVID-19 pandemic has notably amplified the utilization of synthetic biology products over the past two years. In response to the crisis, numerous leading pharmaceutical and biotechnology companies, as well as prominent players in the synthetic biology field, have intensified their research efforts on a global scale. These organizations have employed innovative techniques to produce critical tools such as test kits, therapies, and vaccines for COVID-19. A study by the European Parliament highlights synthetic biology as a developing technology with significant potential applications for addressing COVID-19 infections. Additionally, the U.S. National Institutes of Health has recognized synthetic biology as a crucial tool for expediting vaccine development, underscoring its importance in public health initiatives. This heightened focus on synthetic biology during the pandemic is likely to influence its growth trajectory and expand its applications in the future.

Gather more insights about the market drivers, restrains and growth of the Synthetic Biology Market

Product Insights

Enzymes Segment Dominance (36.79% Market Share in 2024):

1. The enzymes segment held a significant market share of 36.79% in 2024.

2. Enzymes are vital in various biotechnological processes, including:

   1. DNA manipulation

   2. Protein engineering

   3. Metabolic pathway construction

Importance of Enzymes in Multiple Applications:

1. Enzymes are crucial for applications across several sectors, such as:

   1. Pharmaceuticals

   2. Agriculture

   3. Biofuels

2. The demand for efficient and specific biocatalysts drives the market for enzymes.

Versatility and Innovations:

1. The versatility of enzymes facilitates innovations in areas such as:

   1. Gene editing

   2. Synthetic pathways

2. This versatility makes enzymes indispensable in both research and industrial applications.

Advancements in Enzyme Engineering:

1. Recent advancements in enzyme engineering and production technologies have led to:

   1. Enhanced performance of enzymes

   2. Reduced production costs

2. These improvements further solidify the market position of the enzymes segment.

Growing Reliance on Enzymes:

1. As synthetic biology continues to expand, the reliance on enzymes for a diverse range of applications is expected to increase.

Cloning Technologies Kits Segment Growth:

1. The cloning technologies kits segment is projected to experience the fastest compound annual growth rate (CAGR) of 18.43% over the forecast period.

2. These kits simplify the processes involved in:

   1. Gene insertion

   2. Amplification

   3. Modification

3. They make these processes accessible for both research and commercial applications.

Factors Driving Demand for Cloning Technologies:

1. The rise of personalized medicine and innovations driven by synthetic biology fuels the demand for efficient cloning solutions.

2. Growing interest in synthetic organisms and bioengineering projects is accelerating the adoption of cloning technologies.

Outlook for Gene Cloning Methods:

1. As researchers and companies seek faster and more reliable methods for gene cloning, the cloning technologies kits segment is poised for significant growth in the coming years.

Order a free sample PDF of the Synthetic Biology Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com/

Follow Us: LinkedIn | Twitter